Antineoplastic AgentsCell Line, TumorNeoplasmsDoxorubicinDrug Resistance, NeoplasmApoptosisRadiation, IonizingRadiation DosageDrug Screening Assays, AntitumorCisplatinAntibiotics, AntineoplasticCell SurvivalRadiation InjuriesXenograft Model Antitumor AssaysAntineoplastic Agents, PhytogenicRadiation ToleranceDrug SynergismPaclitaxelMice, NudeTumor Cells, CulturedDose-Response Relationship, RadiationCell ProliferationNeoplasms, ExperimentalTumor BurdenDose-Response Relationship, DrugDrug Delivery SystemsTumor Suppressor Protein p53Drug Resistance, MultipleEtoposideTumor Markers, BiologicalP-GlycoproteinBreast NeoplasmsAntineoplastic Combined Chemotherapy ProtocolsRadiationFluorouracilGene Expression Regulation, NeoplasticTumor Necrosis Factor-alphaNeoplasm TransplantationDNA DamageCamptothecinAntimetabolites, AntineoplasticBrain NeoplasmsRadiation ProtectionAntineoplastic Agents, AlkylatingTransplantation, HeterologousColonic NeoplasmsDrug CarriersCell CycleRadiation MonitoringTime FactorsAdenocarcinomaCombined Modality TherapyNeoplasm ProteinsCell DivisionInhibitory Concentration 50Mice, Inbred BALB CSignal TransductionProto-Oncogene Proteins c-bcl-2Neovascularization, PathologicMice, SCIDRadiation-Sensitizing AgentsLung NeoplasmsOvarian NeoplasmsBlotting, WesternTreatment OutcomeCaspasesNeoplasm MetastasisDaunorubicinFlow CytometryRNA, Small InterferingDeoxycytidineLiver NeoplasmsMammary Neoplasms, ExperimentalRNA, MessengerTransfectionEnzyme InhibitorsProdrugsTumor Suppressor ProteinsGamma RaysVinblastineCell LineDNA, NeoplasmDrug ResistanceAngiogenesis InhibitorsCaspase 3Antibodies, MonoclonalCell DeathPancreatic NeoplasmsVincristineFibrosarcomaNanomedicineNeuroblastomaTumor Stem Cell AssayWilms TumorDrug Administration ScheduleMaximum Tolerated DoseReverse Transcriptase Polymerase Chain ReactionMitomycinNanoparticlesGlioma